Profile
ACIU VRTX ALNY REGN ARGX SGEN
Company Name AC Immune S.A. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $245.38M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.13K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Andrea Pfeifer Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ACIU VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
ACIU VRTX ALNY REGN ARGX SGEN
Last Close $2.48 $393.21 $461.14 $572.59 $756.83 $228.74
High 52 $3.78 $516.74 $482.13 $1153.08 $768 $228.74
Low 52 $1.48 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -34.39 % -23.91 % -4.35 % -50.34 % -1.45 % 0 %
Price vs. 52 Week Low 67.57 % 7.28 % 105.33 % 18.57 % 45.61 % 0 %
Total Return
ACIU VRTX ALNY REGN ARGX SGEN
1 Month Return 16.43 % 0.11 % 2.72 % -1.35 % 15.75 % 0 %
3 Month Return 28.5 % -12.8 % 49.34 % 9.55 % 37.3 % 0 %
6 Month Return 8.3 % -22.1 % 90.74 % -14.14 % 25.1 % 0 %
9 Month Return -15.07 % -16 % 89 % -21.01 % 19.63 % 0 %
YTD Return -8.15 % -2.36 % 95.97 % -19.62 % 23.06 % 0 %
1 Year Return -24.16 % -19.66 % 70.56 % -50.34 % 40.69 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -42.88 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
ACIU VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 100 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -26.55 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -49.04 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -54.91 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100.01 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 100.8 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -173.27 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -866.5 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 13.57 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 5.31 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 389.94 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 15.2 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.42 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.43 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 126.34 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -147.39 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.33 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -866.5 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -4.46 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -4.64 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -4.64 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
ACIU VRTX ALNY REGN ARGX SGEN
Revenue $0.03B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0.03B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.05B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.05B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.51 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ACIU VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.12B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.11B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.13B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.01B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.23B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ACIU VRTX ALNY REGN ARGX SGEN
Net Income $-0.05B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.34
AARD Aardvark Therapeutics, Inc. Common Stock 10.24
ABCL AbCellera Biologics Inc. 4.765
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.67
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.22
ABPWW 0.0316
ABSI Absci Corporation 2.705
ABUS Arbutus Biopharma Corporation 4.395
ABVC ABVC BioPharma, Inc. 2.83
ABVX Abivax SA American Depositary Shares 82.28
ACAD ACADIA Pharmaceuticals Inc. 23.96
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8085
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.085
ACLX Arcellx, Inc. 77.34
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01604 140.93
GWX SPDR S&P International Small Cap ETF 0.02 40.33
BIB ProShares Ultra Nasdaq Biotechnology 0.0159544 56.6
SBIO ALPS Medical Breakthroughs ETF 0.002 35.72
BMED BlackRock Future Health ETF 0.0106 26.235
IBBQ Invesco Nasdaq Biotechnology ETF 0.024 23.7
DFAT Dimensional U.S. Targeted Value ETF 0.0001165 58.7
DFAS Dimensional U.S. Small Cap ETF 0.00000797 68.435
DFAC Dimensional U.S. Core Equity 2 ETF 0.00005059 38.305
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02294 5.826
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02294 6.895
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0244 41.615
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02294 6.867
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0244 49.27
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 31.59
DFSU Dimensional US Sustainability Core 1 ETF 0.00026094 42.11
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02294 5.0525
DXUV Dimensional ETF Trust 0.00002414 58.14
Unlock